In Vitro and in Vivo Evidence That the Switch from Calcineurin to Mtor Inhibitors May Be a Strategy for Immunosuppression in Epstein–Barr Virus–associated Post-Transplant Lymphoproliferative Disorder

Constantin J. Thieme,Malissa Schulz,Patrizia Wehler,Moritz Anft,Leila Amini,Arturo Blazquez-Navarro,Ulrik Stervbo,Jochen Hecht,Mikalai Nienen,Anna -Barbara Stittrich,Mira Choi,Panagiota Zgoura,Richard Viebahn,Michael Schmueck-Henneresse,Petra Reinke,Timm H. Westhoff,Toralf Roch,Nina Babel

Kidney International（2022）

Cited 3|Views27

Key words

calcineurin inhibitors,Epstein-Barr virus,immunosuppression,lymphoblastoid cell lines,mycophenolic acid,post-transplant lymphoproliferative disorder,rapamycin,T cells,transplantation

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined